- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07943364
Transcutaneous Auricular Vagus Nerve Stimulation in Perimenopause
Transcutaneous Auricular Vagus Nerve Stimulation in Perimenopause: EEG Signatures of Symptom Modulation
The study will test an ear-based nerve stimulation (taVNS) to see if it can ease common perimenopause symptoms like hot flashes, poor sleep, mood changes, and "brain fog". Along the way, brain activity (EEG) and heart rhythm patterns (HRV) will be tracked to find simple, reliable signs of improvement.
Because women with both mild and more severe symptoms early in the transition are included, the results can learn who benefits most and why. If successful, this study will set the stage for larger trials and could make taVNS a low-risk, affordable option to support women's brain and overall health during perimenopause.
Studieoversikt
Status
Forhold
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion criteria:
- Perimenopausal women aged 35-60 with climacteric symptoms for >6 months, irregular menstruation, and at least one menses in the past 6 months.
- Women on menopausal hormone therapy (HRT).
- Ability to understand procedures and provide informed consent.
- Willingness to complete study visits, questionnaires, EEG/HRV recordings, taVNS sessions.
- Negative urine pregnancy test.
- Access to stable internet for remote sessions or willingness to use study-provided equipment.
Exclusion criteria:
- Pregnancy, breastfeeding, or planning pregnancy during the active study period (for randomized subjects).
- Postmenopausal status.
- History of implanted stimulator.
- Clinically significant unstable cardiac disease.
- History of seizure disorder or serious neurological condition that interferes with study procedures or EEG interpretation.
- Current ear infection.
- Active severe psychiatric instability.
- Recent initiation or major dose change of hormone therapy, psychotropics, beta-blockers, anticholinergics, or other medications likely to substantially affect autonomic or symptom outcomes.
- Current participation in another interventional trial that could confound outcomes.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Trippel
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Active Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
|
Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive neuromodulation technique that delivers mild electrical stimulation to the external ear at regions innervated by the auricular branch of the vagus nerve. |
|
Placebo komparator: Sham Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
|
tAVNS device with electrode placed at the external ear at regions with no active current. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Electroencephalography (EEG)
Tidsramme: Baseline (Visit 2, pre-intervention) and Post Intervention (Visit 13, around 2 weeks from V2)
|
Resting Electroencephalography (EEG) will be recorded using a 64-channel system (resting alpha/theta power) |
Baseline (Visit 2, pre-intervention) and Post Intervention (Visit 13, around 2 weeks from V2)
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 2026P001468
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .